Skip to main content
Equibles
TLSI logo

TLSI · TriSalus Life Sciences, Inc.

Track TLSI — free

Use TLSI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about TLSI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$5.27 -0.36 (-6.39%) At close · Aug 14
Going-concern doubt — cleared Aug 6, 2026

The latest filing no longer states the doubt (first flagged May 12, 2026).

View the 10-Q filed Aug 6, 2026
Market Cap
$324.50M
Shares
61.57M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.27 Open$5.59 Day$5.24–5.64 52W close$2.52–7.50 Avg vol 30d240K Short int3.8M · 6.1% float · 22.2d Short vol54% Last earningsAug 6, 2026 DataFeb 2021–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Buy Momentum Neutral Sentiment Bearish Fundamentals Fair Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +10%
      above
      Price vs 50-day avg +21%
      above
      RSI (14) 61
      neutral
      MACD trend Positive
      52-week position 55%
      mid-range
      Momentum
      relative strength
      Neutral
      1-month return +23%
      trailing
      6-month return +6%
      trailing
      YTD return −25%
      this year
      Relative strength −8%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $4 › 200d $5 — 200d above 50d
      Institutional flow Distributing
      -10% holders QoQ · +13 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      6.13% of float · ▲ +5.9% MoM · 22.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      82 holders — mid 3-yr range
      Squeeze score 76
      high risk · 0–100
      Fundamentals
      Fair
      Revenue growth +53%
      Y/Y
      Gross margin 85%
      contracting
      EPS growth −40%
      Y/Y
      Free cash flow $-18.9M
      Balance sheet $12.6M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 82%
      annualized · 1-yr
      Max drawdown −66%
      past year
      ATR 6.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Full-year 2026 revenue · full-year 2026 $54M – $57M
      Prior guidance period ended · from the 8-K filed Nov 13, 2025
      Full-year revenue growth · full-year 2025 at least 50%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +10% Bullish
      Price vs 50-day avg
      +21% Bullish
      RSI (14)
      61 Neutral
      MACD trend
      Positive Bullish
      52-week position
      55% Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $4 › 200d $5 — 200d above 50d
      Institutional flow Distributing
      -10% holders QoQ · +13 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      6.13% of float · ▲ +5.9% MoM · 22.2 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      82 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $3 Now $5 · 55% Range high $8
      vs 200-day avg +10% vs 50-day avg +21%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted EBITDA non-GAAP -17.2M FY2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      TLSI
      TriSalus Life Sciences, Inc.
      this stock
      		$324.50M -24.5% +53.4% — 6.1%
      ABT
      Abbott Laboratories
      		 $193.78B -11.2% +5.7% 31.2 1.3%
      SYK
      Stryker Corp
      		 $130.11B -3.5% +11.2% 35.2 2.2%
      MDT
      Medtronic plc
      		 $116.83B -5.0% +8.4% 24.5 1.4%
      BSX
      Boston Scientific Corp
      		 $75.11B -45.6% +12.5% 21.0 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      82
      % held
      37.0%
      Net QoQ
      +924.4K sh
      Top holder
      First Light Asset Managem…
      Held Float
      View
      Held by Funds
      Fund positions
      77
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      3.8M
      Days to cover
      22.2d
      Change
      +208.6K sh
      View
      Short Volume
      Short vol %
      54%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      158
      Value
      $654
      As of
      Jul 13, 2026
      View
      Off-Exchange
      Off-exchange %
      30.2%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $45.2M
      Net income (FY)
      $-39.2M
      EPS diluted
      $-1.84
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Aug 12, 2026
      This year
      14
      View
      Proposed Sales
      Value
      $135.0K
      Shares
      30.0K
      Filed
      Dec 10, 2024
      View
      Exempt Offerings
      Offering
      $22.0M
      Filed
      May 8, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 12, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      TLSI -6.1% +22.8% +5.6% +16.1% -24.5%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -6.5% +18.4% -8.2% +12.2% -38.4%
      Key facts CIK 1826667 CUSIP 89680M101 13F (30d) 78 filings 78 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)